Angioplasty, Transluminal, Percutaneous Coronary, Myocardial Infarction, Myocardial Reperfusion
Conditions
Keywords
Transradial access, Femoral access, Femoral vs radial access
Brief summary
The aim of this study is to compare the radial and femoral access for percutaneous interventions in the acute phase of the ST elevation acute myocardial infarction in terms of efficacy and security.
Detailed description
Some groups have previously used the radial artery as the access route in the procedures of percutaneous coronary revascularization, with good results. The advantages of the radial compared with femoral access are related to a lower incidence of vascular complications. The radial access has also inconveniences such as a less predictable anatomy which can make the procedure difficult and prolong the time required.The patients with ST elevation myocardial infarction have an increased risk of vascular complications after interventional procedures because previous antithrombotic or thrombolytic therapy.On the other hand, the time and success of the procedure are significant prognostic issues.In this sitting, the radial approach might reduce vascular complications and increase other cardiovascular events when comparing with the classical femoral access. For this reason, the purpose of the study is to compare both arterial access in terms of efficacy and security and to quantify the consequences of the advantages and drawbacks of both.
Interventions
PROCEDURECoronary angioplasty
Sponsors
Hospital Juan Canalejo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients with ST elevation acute myocardial infarction referred for primary,facilitated or of rescue coronary angioplasty in the first 12 hours since the start of the symptoms.
Exclusion criteria
* Patients in cardiogenic shock were excluded following operator criteria. * Previous coronary surgery with mammary artery graft * Coronary artery intervention in the previous month * Absolute or relative contraindication for access via the radial artery route:Radial pulse absent or weak, abnormal Allen test,anatomy known to impede the use of the radial route or hemodialysis or advanced chronic renal insufficiency (creatinine \>3 mg/dl). * Patients with absolute or relative contraindication for the use of the femoral route. * Absence of informed consent from the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause mortality at 30 days | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
| New ST elevation acute myocardial infarction at 30 days | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
| Coronary revascularization as a result of recurrent ischemia at 30 days | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
| Major vascular complications at 30 days. | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
Secondary
| Measure | Time frame |
|---|---|
| Hospital stay | — |
| Embolic stroke at 30 days | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
| Estimation of costs | — |
| Coronary revascularization at 30 days | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
| Cardiovascular mortality at 30 days | within the first 30 days (plus or minus 5 days) after the index myocardial infarction |
| Procedural time | — |
Countries
Spain
Outcome results
None listed